The	O
effect	O
of	O
type	O
and	O
volume	O
of	O
fluid	O
hydration	O
on	O
labor	B:C0566679
duration	I:C0566679
of	O
nulliparous	O
women	O
:	O
a	O
randomized	O
controlled	I:C0206035
trial	I:C0206035
Type	O
and	O
volume	O
of	O
fluid	O
administered	O
for	O
intrapartum	O
maintenance	O
had	O
been	O
reported	O
to	O
differently	O
affect	O
labor	O
length	I:C0566679
,	O
delivery	O
mode	O
,	O
and	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
.	O

The	O
effect	O
of	O
type	O
and	O
volume	O
of	O
fluid	O
hydration	O
on	O
labor	O
duration	I:C0566679
of	O
nulliparous	B:C0425979
women	O
:	O
a	O
randomized	O
controlled	I:C0206035
trial	I:C0206035
Type	O
and	O
volume	O
of	O
fluid	O
administered	O
for	O
intrapartum	O
maintenance	O
had	O
been	O
reported	O
to	O
differently	O
affect	O
labor	O
length	I:C0566679
,	O
delivery	O
mode	O
,	O
and	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
.	O

The	O
effect	O
of	O
type	O
and	O
volume	O
of	O
fluid	O
hydration	O
on	O
labor	O
duration	I:C0566679
of	O
nulliparous	O
women	B:C0043210
:	O
a	O
randomized	O
controlled	I:C0206035
trial	I:C0206035
Type	O
and	O
volume	O
of	O
fluid	O
administered	O
for	O
intrapartum	O
maintenance	O
had	O
been	O
reported	O
to	O
differently	O
affect	O
labor	O
length	I:C0566679
,	O
delivery	O
mode	O
,	O
and	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
.	O

The	O
effect	O
of	O
type	O
and	O
volume	O
of	O
fluid	O
hydration	O
on	O
labor	O
duration	I:C0566679
of	O
nulliparous	O
women	O
:	O
a	O
randomized	B:C0206035
controlled	I:C0206035
trial	I:C0206035
Type	O
and	O
volume	O
of	O
fluid	O
administered	O
for	O
intrapartum	O
maintenance	O
had	O
been	O
reported	O
to	O
differently	O
affect	O
labor	O
length	I:C0566679
,	O
delivery	O
mode	O
,	O
and	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
.	O

The	O
effect	O
of	O
type	O
and	O
volume	O
of	O
fluid	O
hydration	O
on	O
labor	O
duration	I:C0566679
of	O
nulliparous	O
women	O
:	O
a	O
randomized	O
controlled	I:C0206035
trial	I:C0206035
Type	O
and	O
volume	O
of	O
fluid	O
administered	O
for	O
intrapartum	O
maintenance	O
had	O
been	O
reported	O
to	O
differently	O
affect	O
labor	B:C0566679
length	I:C0566679
,	O
delivery	O
mode	O
,	O
and	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
.	O

The	O
effect	O
of	O
type	O
and	O
volume	O
of	O
fluid	O
hydration	O
on	O
labor	O
duration	I:C0566679
of	O
nulliparous	O
women	O
:	O
a	O
randomized	O
controlled	I:C0206035
trial	I:C0206035
Type	O
and	O
volume	O
of	O
fluid	O
administered	O
for	O
intrapartum	O
maintenance	O
had	O
been	O
reported	O
to	O
differently	O
affect	O
labor	O
length	I:C0566679
,	O
delivery	B:C0005615
mode	O
,	O
and	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
.	O

The	O
effect	O
of	O
type	O
and	O
volume	O
of	O
fluid	O
hydration	O
on	O
labor	O
duration	I:C0566679
of	O
nulliparous	O
women	O
:	O
a	O
randomized	O
controlled	I:C0206035
trial	I:C0206035
Type	O
and	O
volume	O
of	O
fluid	O
administered	O
for	O
intrapartum	O
maintenance	O
had	O
been	O
reported	O
to	O
differently	O
affect	O
labor	O
length	I:C0566679
,	O
delivery	O
mode	O
,	O
and	O
cord	B:C1185921
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
.	O

The	O
effect	O
of	O
type	O
and	O
volume	O
of	O
fluid	O
hydration	O
on	O
labor	O
duration	I:C0566679
of	O
nulliparous	O
women	O
:	O
a	O
randomized	O
controlled	I:C0206035
trial	I:C0206035
Type	O
and	O
volume	O
of	O
fluid	O
administered	O
for	O
intrapartum	O
maintenance	O
had	O
been	O
reported	O
to	O
differently	O
affect	O
labor	O
length	I:C0566679
,	O
delivery	O
mode	O
,	O
and	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	B:C0428548
level	I:C0428548
.	O

We	O
aimed	O
to	O
compare	O
the	O
effect	O
of	O
three	O
different	O
fluid	O
regimens	B:C2945654
on	O
labor	O
duration	I:C0566679
.	O

We	O
aimed	O
to	O
compare	O
the	O
effect	O
of	O
three	O
different	O
fluid	O
regimens	O
on	O
labor	B:C0566679
duration	I:C0566679
.	O

In	O
a	O
randomized	B:C0206034
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	O
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	O
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	B:C0425979
in	O
labor	O
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	O
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	B:C0022864
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	O
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	O
were	O
randomized	B:C0034656
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	O
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	O
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	B:C0348016
fluid	O
regimens	O
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	O
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	B:C2945654
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	O
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	O
:	O
group	B:C0441861
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	O
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	O
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	B:C0073385
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	O
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	O
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	B:C0441865
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	O
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	O
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	B:C0073385
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	O
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

In	O
a	O
randomized	O
trial	I:C0206034
,	O
healthy	O
nulliparous	O
in	O
labor	O
were	O
randomized	O
into	O
one	O
of	O
three	O
intravenous	O
fluid	O
regimens	O
:	O
group	O
1	I:C0441861
,	O
the	O
reference	O
group	O
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
;	O
group	O
2	I:C0441865
,	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
infused	O
at	O
a	O
rate	O
of	O
250	O
mL	O
/	O
h	O
;	O
group	B:C0441869
3	I:C0441869
,	O
0.9	O
%	O
saline	O
solution	O
boosted	O
with	O
5	O
%	O
glucose	O
,	O
infused	O
at	O
a	O
rate	O
of	O
125	O
mL	O
/	O
h	O
.	O

The	O
primary	O
outcome	O
was	O
labor	B:C0566679
length	I:C0566679
from	O
enrollment	O
until	O
delivery	O
.	O

The	O
primary	O
outcome	O
was	O
labor	O
length	I:C0566679
from	O
enrollment	B:C1516879
until	O
delivery	O
.	O

The	O
primary	O
outcome	O
was	O
labor	O
length	I:C0566679
from	O
enrollment	O
until	O
delivery	B:C0005615
.	O

Between	O
December	O
2010	O
and	O
July	O
2015	O
,	O
300	O
women	B:C0043210
were	O
randomized	O
to	O
one	O
of	O
the	O
three	O
groups	O
.	O

Between	O
December	O
2010	O
and	O
July	O
2015	O
,	O
300	O
women	O
were	O
randomized	B:C0034656
to	O
one	O
of	O
the	O
three	O
groups	O
.	O

Demographic	O
and	O
baseline	O
obstetric	B:C0022864
characteristics	O
were	O
comparable	O
between	O
the	O
groups	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
time	O
from	O
enrollment	B:C1516879
to	O
delivery	O
(	O
p	O
=	O
0.62	O
)	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
time	O
from	O
enrollment	O
to	O
delivery	B:C0005615
(	O
p	O
=	O
0.62	O
)	O
.	O

Furthermore	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
second	B:C0474477
stage	I:C0474477
duration	I:C0474477
(	O
p	O
=	O
0.73	O
)	O
,	O
mode	O
of	O
delivery	O
(	O
p	O
=	O
0.21	O
)	O
,	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
between	O
the	O
groups	O
.	O

Furthermore	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
second	O
stage	I:C0474477
duration	I:C0474477
(	O
p	O
=	O
0.73	O
)	O
,	O
mode	O
of	O
delivery	B:C0005615
(	O
p	O
=	O
0.21	O
)	O
,	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
between	O
the	O
groups	O
.	O

Furthermore	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
second	O
stage	I:C0474477
duration	I:C0474477
(	O
p	O
=	O
0.73	O
)	O
,	O
mode	O
of	O
delivery	O
(	O
p	O
=	O
0.21	O
)	O
,	O
cord	B:C1185921
artery	I:C1185921
pH	O
and	O
glucose	O
level	I:C0428548
between	O
the	O
groups	O
.	O

Furthermore	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
second	O
stage	I:C0474477
duration	I:C0474477
(	O
p	O
=	O
0.73	O
)	O
,	O
mode	O
of	O
delivery	O
(	O
p	O
=	O
0.21	O
)	O
,	O
cord	O
artery	I:C1185921
pH	O
and	O
glucose	B:C0428548
level	I:C0428548
between	O
the	O
groups	O
.	O

Increasing	O
the	O
intravenous	B:C0348016
volume	O
of	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
or	O
substituting	O
to	O
fluid	O
containing	O
5	O
%	O
glucose	O
solution	O
does	O
not	O
affect	O
labor	O
length	I:C0566679
.	O

Increasing	O
the	O
intravenous	O
volume	O
of	O
lactated	B:C0073385
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
or	O
substituting	O
to	O
fluid	O
containing	O
5	O
%	O
glucose	O
solution	O
does	O
not	O
affect	O
labor	O
length	I:C0566679
.	O

Increasing	O
the	O
intravenous	O
volume	O
of	O
lactated	O
Ringer	I:C0073385
's	I:C0073385
solution	I:C0073385
or	O
substituting	O
to	O
fluid	O
containing	O
5	O
%	O
glucose	O
solution	O
does	O
not	O
affect	O
labor	B:C0566679
length	I:C0566679
.	O

ClinicalTrials.gov	O
,	O
http://www.clinicaltrials.gov,	O
NCT01242293	B:C3274381
.	O

